Literature DB >> 8137007

'Bálint's syndrome' and associated visuospatial disorders.

M Rizzo1.   

Abstract

There are several objections to the need for the designation 'Bálint's syndrome'. The full syndrome is generally associated with a wide variety of behavioural disturbances outside Bálint's original triad that may confound the interpretation of their supposed defect. It embeds itself in the hemineglect syndrome, violating the principle of autonomy for a syndrome. Individual components of the triad, particularly simultanagnosia, may represent relatively broad categories that subsume other combinations of defects of widely different degrees of severity. The diagnosis fails to predict a consistent site of anatomical impairment, and the main proposed mechanism is not sound. Our experience with a registry of patients with focal brain lesions and well-documented behavioural impairments (Palca, 1990), now numbering over 1500 individuals, tends to support these generalizations.

Entities:  

Mesh:

Year:  1993        PMID: 8137007

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  5 in total

Review 1.  Neurovisual rehabilitation: recent developments and future directions.

Authors:  G Kerkhoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

Review 2.  Psychoanatomical substrates of Bálint's syndrome.

Authors:  M Rizzo; S P Vecera
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

3.  Recognition without awareness in a patient with simultanagnosia.

Authors:  Natalie L Denburg; Robert D Jones; Daniel Tranel
Journal:  Int J Psychophysiol       Date:  2008-09-13       Impact factor: 2.997

Review 4.  Psychological processing in chronic pain: a neural systems approach.

Authors:  Laura E Simons; Igor Elman; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2013-12-27       Impact factor: 8.989

5.  The enigma of Bálint's syndrome: neural substrates and cognitive deficits.

Authors:  Magdalena Chechlacz; Glyn W Humphreys
Journal:  Front Hum Neurosci       Date:  2014-03-07       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.